Patenting Nanomedicines

The rapid expansion of nanomedical methods and applications makes careful patenting essential in this field. This comprehensive survey of the process explains the law and examines current debates on urgent issues such as the effect of patent law on innovation.

Patenting Nanomedicines: Legal Aspects, Intellectual Property and Grant Opportunities focusses on the fundamental aspects of Patenting Nanomedicines applied in different Drug Delivery and Targeting Systems. The promoters of new findings in this field of research are numerous and spread worldwide; therefore, managing intellectual property portfolios, and the acquisition and exploitation of new knowledge face several contingency factors. Today, the scientific community is discussing issues of economic outcomes in the field of Nanomedicines. Major concerns include questions as to whether the research groups, academics, industry and other stakeholders should work in unison or independently, if innovation or adaptation of new technology should be prioritized, public versus private research funding, and safeguarding versus sharing knowledge. However, despite its increasing importance for humankind, it is a matter of concern as to whether technological development can really be stimulated by patent protection. An intellectual property strategy should aim to develop a qualitative patent portfolio for continuous learning.

This book addresses questions of ethics, socio-political policies and regulatory aspects of novel Nanomedicine-based products which are currently under development for the diagnosis and treatment of different types of diseases. It is divided in two parts Part I is composed of the first 3 chapters, which focus on the fundamentals of legal aspects, emerging threats, advantages and disadvantages of patenting Nanomedicines, whereas Part II collects 12 chapters discussing different types of Nanomedicine-based products, their potential marketing aspects and patent protection. Whenever applied, each chapter offers a list of patents, based on a specific application in drug delivery and targeting. An outstanding team of 53 authors have contributed to this book, which will be ofinterest to professionals from the field of patent examiners, academics, researchers and scientists, students and other practitioners.

Comprehensive state-of-the-art review about the diversity of patent applications Drives the reader to the theories and threats, applications and challenges to succeed a patent application process In-depth and thorough texts' dissection and conceptional reasoning from a comprehensive legal perspective Includes supplementary material: sn.pub/extras

Klappentext

The book focusses on the fundamental aspects of Patenting Nanomedicines applied in different Drug Delivery and Targeting Systems. The promoters of new findings in this field of research are numerous and spread worldwide; therefore, managing intellectual property portfolios, and the acquisition and exploitation of new knowledge face several contingency factors. Major concerns include questions as to whether the research groups, academics, industry and other stakeholders should work in unison or independently, if innovation or adaptation of new technology should be prioritized, public versus private research funding, and safeguarding versus sharing knowledge. However, despite its increasing importance for humankind, it is a matter of concern as to whether technological development can really be stimulated by patent protection. An intellectual property strategy should aim to develop a qualitative patent portfolio for continuous learning.

This book addresses questions of ethics, socio-political policies and regulatory aspects of novel Nanomedicine-based products which are currently under development for the diagnosis and treatment of different types of diseases. It is divided in two parts Part I is composed of the first 3 chapters, which focus on the fundamentals of legal aspects, emerging threats, advantages and disadvantages of patenting Nanomedicines, whereas Part II collects 12 chapters discussing different types of Nanomedicine-based products, their potential marketing aspects and patent protection. Whenever applied, each chapter offers a list of patents, based on a specific application in drug delivery and targeting. An outstanding team of 53 authors have contributed to this book, which will be of interest to professionals from the field of patent examiners, academics, researchers and scientists, students and other practitioners.

Inhalt

Part I Fundamentals: S. Puthli/M. S. Puthli/A. S. Macedo/E. B. Souto, Intellectual Property and Nanopharmaceuticals.- R. S. R. Murthy, Challenges and Emerging issues in Patenting Nanomedicines.- V. Pillay/Y. E. Choonara/P. Kumar/V. M. K. Ndesendo/L. C. du Toit, Legislative measures for in vitro/in vivo correlations and pharmacokinetic modelling.- Part II Case Studies in Patenting Drug Delivery and Targeting Systems: J. Ali/Md. Shadab/S. Baboota/J. K. Sahni, Polymeric Nanoparticles, Magnetic Nanoparticles and Quantum Dots Current and Future Perspectives.- T. Andreani/A. L. R. de Souza/A. M. Silva, E. B. Souto, Sol-gel Nanomedicines: A novel controlled drug delivery.- G. Caruso/M. Caffo/G. Raudino/C. Tomasello/C. Alafaci/F. Tomasello, Nanomedicine and Brain Tumors Treatment.- A. D'Souza/S. Pranatharthiharan/P. V. Devarajan, Nanomedicines for Nucleic Acid Therapy.- V. Bali/S. Singh/A. Kumar, Nanomedicines for Nasal Drug Delivery.- A. Al-kinani/G. Calabrese/A. Vangala/D. Naughton/R. Alany, Nanomedicines for Ocular Drug Delivery.- M. Özyazc/E. H. Gökçe/A. Yurdasiper, Nanosized Drug Delivery Systems for Enhancement of Oral Bioavailability.- T. W. Wong/U. Mandal/L.-J. Shen, Chitosan and Alginate Nanoparticles as Oral Insulin Carriers.- P. Boonme, Patenting Nanomedicines for Nutraceutical Ingredients.- R. Saraceno/A. Chiricozzi/E. Botti/T. Gramiccia/L. Pietroleonardo/S. Chimenti, Nanomedicines inDermatology: Benefits and Emerging Applications.- K. K. Singh, Nanomedicines in Malaria.- J. F. Fangueiro/P. Severino/M. H. A. Santana/S. B. Souto/E. B. Souto, Nanomedicines for immunization and vaccines.